Treating Seizures and Improving Newborn Outcomes for Infants with Hypoxic-Ischemic Encephalopathy

Tayyba Anwar,Regina L. Triplett,Afaf Ahmed,Hannah C. Glass,Renée A. Shellhaas
DOI: https://doi.org/10.1016/j.clp.2024.04.013
IF: 2.642
2024-05-24
Clinics in Perinatology
Abstract:• Continuous electroencephalographic monitoring is recommended for neonates with hypoxic-ischemic encephalopathy (HIE) to screen for seizures and evaluate evolution of the interictal background. • Early recognition and effective treatment of seizures are key priorities for neonatal neurointensive care. • First-line antiseizure medication remains phenobarbital while second line may include fosphenytoin, levetiracetam, or continuous infusions. • Early discontinuation of antiseizure medication is safe in Continuous electroencephalographic monitoring is recommended for neonates with hypoxic-ischemic encephalopathy (HIE) to screen for seizures and evaluate evolution of the interictal background. Early recognition and effective treatment of seizures are key priorities for neonatal neurointensive care. First-line antiseizure medication remains phenobarbital while second line may include fosphenytoin, levetiracetam, or continuous infusions. Early discontinuation of antiseizure medication is safe in
pediatrics,obstetrics & gynecology
What problem does this paper attempt to address?